Dr. Robert Gabel, MD

NPI: 1164419206
Total Payments
$414.30
2017 Payments
$414.30
Companies
8
Transactions
11

Payment Breakdown by Category

Food & Beverage$414.30 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $414.30 11 100.0%

Top Paying Companies

Company Total Records Latest Year
Merck Sharp & Dohme Corporation $154.36 2 $0 (2017)
PFIZER INC. $129.46 2 $0 (2017)
Endo Pharmaceuticals Inc. $44.63 2 $0 (2017)
Astellas Pharma US Inc $22.88 1 $0 (2017)
GlaxoSmithKline, LLC. $20.33 1 $0 (2017)
Janssen Pharmaceuticals, Inc $17.25 1 $0 (2017)
Novo Nordisk Inc $14.54 1 $0 (2017)
Amgen Inc. $10.85 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2017 $414.30 11 Merck Sharp & Dohme Corporation ($154.36)

All Payment Transactions

11 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
11/28/2017 Endo Pharmaceuticals Inc. NASCOBAL (Drug) Food and Beverage In-kind items and services $26.31 General
Category: PRESCRIPTION SUPPLEMENT
09/26/2017 GlaxoSmithKline, LLC. BREO (Drug) Food and Beverage In-kind items and services $20.33 General
Category: RESPIRATORY
09/19/2017 Endo Pharmaceuticals Inc. NASCOBAL (Drug) Food and Beverage In-kind items and services $18.32 General
Category: PRESCRIPTION SUPPLEMENT
09/05/2017 Novo Nordisk Inc Victoza (Drug), Tresiba Food and Beverage In-kind items and services $14.54 General
Category: Diabetes
08/29/2017 Astellas Pharma US Inc Myrbetriq (Drug), Vesicare Food and Beverage In-kind items and services $22.88 General
Category: Urology
06/20/2017 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $17.25 General
Category: Cardiovascular & Metabolism
04/28/2017 Amgen Inc. Prolia (Biological), Repatha Food and Beverage In-kind items and services $10.85 General
Category: Endocrinology
04/11/2017 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $3.86 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
03/15/2017 Merck Sharp & Dohme Corporation JANUVIA (Drug) Food and Beverage In-kind items and services $82.72 General
Category: ENDOCRINOLOGY
02/16/2017 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $125.60 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
01/26/2017 Merck Sharp & Dohme Corporation JANUVIA (Drug) Food and Beverage In-kind items and services $71.64 General
Category: ENDOCRINOLOGY

About Dr. Robert Gabel, MD

Dr. Robert Gabel, MD is a Specialist healthcare provider based in Red Bank, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1164419206.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Gabel, MD has received a total of $414.30 in payments from pharmaceutical and medical device companies, with $414.30 received in 2017. These payments were reported across 11 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($414.30).

Practice Information

  • Specialty Specialist
  • Other Specialties Rheumatology
  • Location Red Bank, NJ
  • Active Since 10/04/2005
  • Last Updated 08/15/2017
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1164419206

Products in Payments

  • JANUVIA (Drug) $154.36
  • XELJANZ (Drug) $129.46
  • NASCOBAL (Drug) $44.63
  • Myrbetriq (Drug) $22.88
  • BREO (Drug) $20.33
  • XARELTO (Drug) $17.25
  • Victoza (Drug) $14.54
  • Prolia (Biological) $10.85

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in Red Bank